Member Info for Balanced66

People beginning to slowly realise what good value we are and we have a RTO or acquisition type investment hopefully coming as well and to look forward to.

You have a nice afternoon also Scoredagainsteps. I'm very relaxed about my holding here.

I want to be fair in my posting and this is what rikkitikki said in the earlier post expressing doubts about selling make of that what you will;

"Agree with everything you've said. Now I'm out, i'm 'hoping' that ETON is already in the price... and Chronocort is going to take time to build up the sp."

Scoredagainsteps I think rikkitikki said he/she has sold already. I don't know what it is with the regular negative posts. We all know these risks as we are biotech investors. In one of the posts he/she mentioned I think about wanting to buy back. I have nothing against exchange of views but this is now the second or third post making the same points. Clearly having sold rikkitikki is concerned about our well being!

From what I can see Eton were only out by 10% from the expected results so the results for the year/last quarter weren't expected to be great to begin with.

This site offers some more information/opinion:

https://spongeshare.com/research/170-2/

https://oilprice-com.cdn.ampproject.org/v/s/oilprice.com/Energy/Energy-General/Three-Commodities-Set-To-Boom-As-The-Global-Economy-Recovers.amp.html?amp_js_v=a6&_gsa=1&usqp=mq331AQFKAGwASA%3D#aoh=16160582882585&csi=1&referrer=https%3A%2F%2Fwww.google.com&_tf=From%20%251%24s&share=https%3A%2F%2Foilprice.com%2FEnergy%2FEnergy-General%2FThree-Commodities-Set-To-Boom-As-The-Global-Economy-Recovers.html

https://oilprice-com.cdn.ampproject.org/v/s/oilprice.com/Energy/Energy-General/Three-Commodities-Set-To-Boom-As-The-Global-Economy-Recovers.amp.html?amp_js_v=a6&_gsa=1&usqp=mq331AQFKAGwASA%3D#aoh=16160582882585&csi=1&referrer=https%3A%2F%2Fwww.google.com&_tf=From%20%251%24s&share=https%3A%2F%2Foilprice.com%2FEnergy%2FEnergy-General%2FThree-Commodities-Set-To-Boom-As-The-Global-Economy-Recovers.html

Thanks Bojo always good to do your research and you have. Hope it works out well for you.

I'm limited for funds at the moment as pretty much fully invested at the moment.

Any thoughts on ACP - I haven't looked at them properly but aren't they looking to do something similar and become a producer soon?

Exciting times ahead. He did say when the questioner regretted not buying any shares earlier that it was just the beginning.

Another share heading for midcap status in the not too distant future imv.

Bojo

Thanks for highlighting this share and the YouTube link which I did watch and agree it is an interesting share.

It has shot up quickly recently so probably too high for me. It is nearing production. Has it secured finance?

There are risks with companies heading for first production/mine development such as delays and extra costs.

Is there nothing in UK that is similar? What about Armdale (ACP)?

Hi Ghrtrader

Thanks for the technical analysis. How have you got us up 200% since November last year?

By my maths and it's not usually the best if you take the low point in November on the Google chart we were 2.17p on the 2nd November 2020. This by the way is the 1 day low point on the Google chart since the 3rd of June 2020 when it was 2.88p. Using the 1 day low point of the 2nd November 2020 is therefore not going to give the correct picture of the share price performance for most of the last 12 months when it has been much higher than 2.17p and has been at 3.6p as well and over 3p many times as well. The 200 day moving average is 3.03 so we are not yet at 100% based on that measure.

Even using the very low point of that one day in November last year still means the share price needs to get to 6.51p before it has increased 200%.

Although the technicals may have been showing it approaching overbought a few days ago it no longer is imv. Any share can fall as low as you suggest but that would be some retrace when this share was way oversold or way undervalued for a long time. I can't see it happening myself because of the very strong fundamentals and profit forecasts which are also likely to be upgraded as well due to the improving business and oil price at such levels above $50. One of the websites is still forecasting a 12 month price earnings ratio of 3.7! This is likely to be inaccurate when production is upgraded so all the upside left imv.

I like this website a lot as it provides technical analysis which I'm not very good at so check it now and then and I think it was saying approacing overbought territory a few days ago but it isn't now:

https://www.barchart.com/stocks/quotes/UOG.LN/overview

I don't rely on charts but prefer looking at fundamentals - however even the most undervalued share will not go up in a straight line and you are right there that it has to do its chart thing and go through the points of consolidation on the way up.

I'm more interested in the technology working and today confirms it does. This will open up a raft of tests for other uses and that is why I'm invested here.

I read it as positive. It was launched late in the last quarter so revenues weren't going to be great. As year end is December.

But this is what they say: "New patient starts have grown every month since launch, and the company expects the growth to continue." "Significant adoption " is also mentioned so this is telling us how the adoption of the product is going after year end. They want to immediately supply Canadian market. Not wasting any time. I'm happy with that RNS. The prize is still Chronocort.

"Launch of ALKINDI® SPRINKLE. Eton launched ALKINDI SPRINKLE late in the fourth quarter of 2020. Initial reception from patients and pediatric endocrinologists has been strong and the company has already seen significant adoption of the product."

"ALKINDI SPRINKLE

Eton launched ALKINDI SPRINKLE in late 2020 and promotional activities have accelerated in 2021. The company’s pediatric endocrinology focused sales force has now reached a large number of the company’s initial targets. In addition to virtual meetings, sales reps are beginning to hold in-person meetings with prescribers as COVID restrictions have started to ease. The company expects the rate of in-person meetings to increase in the coming months, which is expected to drive even greater adoption of ALKINDI SPRINKLE. New patient starts have grown every month since launch, and the company expects the growth to continue.

Due to the strong initial reception to ALKINDI SPRINKLE in the United States and inbound interest from Canadian patients and physicians, Eton acquired the Canadian rights to ALKINDI SPRINKLE in January 2021. Eton is exploring the possibility of immediately supplying the product to patients through Canada’s Special Access Program while it works on compiling the product’s regulatory application to seek formal approval from Health Canada."

I don't know how these things work but I think that's maybe all they could get as it was significantly oversubscribed? Bracco already hold and so the placing was divided with others to give them a chance to hold possibly. Will be waiting to see who the US based investors are. Maybe D1 Capital amongst them?

Yes happy with the placing price - it's hit that level a few times in the last few months and has held above 70p for a while only. So a good achievement. For a company awaiting FDA approval it shows the level of institutional and other interest. Also not just oversubscribed but "significantly" so. The directors have added to their holdings as has Amati whom I respect as a fund manager; believe this was the share they said they would hold for 10 years and Bracco have increased significantly.

Bracco are described as "the world-leading diagnostic imaging provider" so the world leader increasing their shares held.

Bracco have an acquisitive past if you read the Wikipedia page for a summary.

Destiny

I should have got some more for my other account as well. Have around 3.5 % in pension which is almost a free carry now after first buying at around 30pish and then 55pish.

Company seem really positive about the progress made and have 2 potential drugs ready for phase 3 after hopefully one of them passing phase 2 - we should find out in the next few weeks hopefully if it has cleared p2.

Always liked the business and funding sorted as well.

Oh well can't be buying everything!

Thanks for that I'll post that article on the ATM board where I also have a holding.

Sorry Maf - the autocorrect changed what I typed.

Morning Mad

I don't use Level 2 but came across this news announcement which suggests you can get L2:

https://www.londonstockexchange.com/news-article/AFN/addition-of-aquis-exchange-data-to-advfn-level-2/14435581?lang=en

https://www.lse.co.uk/Level2SharePrice.asp?shareprice=AQX&share=Aquis-Exchange

The problem is that a lot of brokers don't yet offer dealing on this exchange which needs to change:

chris akers (@sportschris) Tweeted:
Will the following brokers and platforms please start offering their private clients the ability to trade in Aquis Stock Exchange stocks #AQSE with immediate effect with live prices. @HLInvest @AJBellYouinvest @ii_couk @********** @HalifaxBank @IGCom @ETXCapital https://twitter.com/sportschris/status/1370677456856813569?s=20

I don't follow Chris Asker's but a lot of pi's are following his every move to make money?

Fekir

Feel your pain. I had a holding a few months ago. It was only around 2% or so I think of pf. Think I bought around 3.3 and sold around 2.67. I agree with the advice given so far. I wouldn't put anymore money in it. It's very speculative and the fact that the share price has been declining all this time is a sign that the company hasn't delivered much to date - I remember the frustrated holders on the Lse BB. It might just be throwing good money after bad.

I didn't buy it on fundamentals. I was watching all these covid stocks going up and then came across Nfx and it had dropped to the near low for the year (bought last year). It also mentioned a drug program that had potential for covid use/development and I thought this one would go up a lot like the other ones in covid space had! How wrong I was. It did go up around 25-30% for a few minutes and then in the days after I think it did another 20% or so. I was waiting for the big increases and as my stake was small thought I would hold on. But after November and vaccine news it wasn't really going anywhere and it became clear to me that covid wasn't really the focus of the company as far as I could tell. Plus the advice is that if the story changes then sell. I had invested for the covid aspect and that wasn't happening (not yet at least) so I sold and took the small loss.

I'm not the best trader and don't always come out well in this situations but I think luckily I am still up on my trading due to the Arix Bio trade where I made 50% on a 10% stake in less than an hour.

I will stay on the whole with the approach of looking for undervalued companies as that has worked out better for me to date. I'm keen to learn and assimilate new approaches though.

One experienced trader I was chatting to uses all the trading tools such as Fibonacci retracements, ABC reversals, trend lines etc. All interestimg stuff and it works for him he was up over 30% since the start of the year and did about 60% in one of his accounts last year. I will look into that method of trading in future hopefully.